Biomaterials Science · 2022 · 22 citations · 35 references
MedicineCancer BiologyOncologyCancer ImmunologyDrug DeliveryTumor MicroenvironmentCancer ImmunotherapyCancer NanomedicineCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsNanomedicineTumor Microenvironment ModulationCancer Immunotherapy NanoparticlesCancer NanotherapyNanoparticle-based ChemotherapyTumor Microenvironment EffectsTumor Microenvironment ResponsivenessTumor Microenvironment-responsive TargetingTumor-targeted Drug Delivery
synergistically triggers higher ICD with the release of the high mobility group box-1 (HMGB-1) and calreticulin (CRT). After intravenous injection of DMP@NPs, the local tumor microenvironment of CT26 tumor-bearing mice was reprogrammed, and dendritic cell activation and T cell infiltration were significantly increased. Most importantly, the synergistic immune nanodrug DMP@NPs improved the efficacy of colorectal cancer immunotherapy and reduced toxicity and side effects for the immune organs.
35
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations
Life Sciences, Immunology, Oncology +17
Colorectal cancer statistics, 2020
Rebecca L. Siegel, Kimberly D. Miller, Ann Goding Sauer et al. · CA A Cancer Journal for Clinicians · 2020 · 5.1K citations · Full text
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obéid, Antoine Tesnière, François Ghiringhelli et al. · Nature Medicine · 2006 · 3.1K citations
Medicine, Immunology, Oncology +14